Cue Biopharma Share Price (NASDAQ: CUE)
$0.82
▲
0.01
(1.23%)
Live
Last updated on
Check the interactive Cue Biopharma Stock chart to analyse performance
Cue Biopharma Inc Key Stats
Check Cue Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Cue Biopharma Stock including INR - Dollar returns
The Cue Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cue Biopharma investment value today
Current value as on today
₹1,04,255
Returns
₹4,255
(+4.25%)
Returns from Cue Biopharma Stock
₹0 (0%)
Dollar Returns*
₹4,255 (+4.25%)
Indian investors sentiment towards Cue Biopharma Stock
Global Institutional Holdings in Cue Biopharma Inc
Name
Holdings %
Bleichroeder LP
6.54%
Vanguard Group Inc
4.17%
Geode Capital Management, LLC
0.91%
BlackRock Inc
0.83%
Robertson Stephens Wealth Management, LLC
0.63%
Bank of America Corp
0.42%
Analyst Recommendation on Cue Biopharma Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Cue Biopharma(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Cue Biopharma Share Price Target
What analysts predicted
Upside of 387.8%
Target:
$4.00
Current:
$0.82
Cue Biopharma share price target is $4.00, a slight Upside of 387.8% compared to current price of $0.82 as per analysts' prediction.
Cue Biopharma Stock Insights
Price Movement
In the last 6 months, CUE stock has moved down by -38.4%Increasing Revenue
Revenue is up for the last 2 quarters, 421.0K → 2.95M (in $), with an average increase of 85.8% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -12.25M → -8.48M (in $), with an average increase of 44.5% per quarterCUE vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 68.5%CUE vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 114.2% return, outperforming this stock by 187.5%Price to Sales
ForCUE every $1 of sales, investors are willing to pay $7.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.6 for every $1 of sales.
Cue Biopharma Inc Financials
Cue Biopharma Technicals Summary
Sell
Neutral
Buy
Cue Biopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Cue Biopharma Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -8.62% | -38.39% | -0.22% | -74.74% | -95.63% |
 | 4.5% | -14.59% | -49.64% | -0.73% | 0.56% |
 | 6.48% | 22.93% | 60.47% | 81.44% | 32.24% |
 | -16.69% | -17.94% | -17.2% | 38.81% | 48.58% |
 | 43.34% | 86.27% | 68.31% | 115.22% | 254.29% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.45 | -1.96 | -0.59 | NA | 0.24 |
| 14.9 | 14.9 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 28.01 | 28.01 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $62.4M | -95.63% | NA | 0.0% |
| Buy | $62.6B | 0.56% | 14.9 | 31.37% |
| NA | $37.6B | 32.24% | NA | -3.89% |
| Buy | $101.1B | 48.58% | 28.01 | 31.86% |
| Buy | $60.1B | 254.29% | NA | -12.96% |
About Cue Biopharma Inc
Key Management of Cue Biopharma Inc
Important FAQs about investing in CUE Stock from India :
What is Cue Biopharma share price today?
Cue Biopharma share price today is $0.82 as on . Cue Biopharma share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
What is the 52 week high and 52 week low for Cue Biopharma share?
Cue Biopharma share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Cue Biopharma stock price today i.e. is trending at $0.82, lower by 58.78% versus the 52 week high.
How to invest in Cue Biopharma Stock (CUE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Cue Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cue Biopharma Shares that will get you 1.8293 shares as per Cue Biopharma share price of $0.82 per share as on August 23, 2025 at 12:39 AM IST.
What is the minimum amount required to buy Cue Biopharma Stock (CUE) from India?
Indian investors can start investing in Cue Biopharma (CUE) shares with as little as ₹87.499 or $1 (as of August 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.99 in Cue Biopharma stock (as per the Rupee-Dollar exchange rate as on August 22, 2025).
Based on Cue Biopharma share’s latest price of $0.82 as on August 23, 2025 at 12:39 AM IST, you will get 12.1951 shares of Cue Biopharma. Learn more about
fractional shares .
What are the returns that Cue Biopharma has given to Indian investors in the last 5 years?
Cue Biopharma stock has given -95.63% share price returns and 17.97% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
Brightspire Capital, Inc.$5.70
+3.83%
Gladstone Land Corporation$9.17
+2.92%
- Rckefllr Gbl Eqt Etf
$28.69
+1.31%
- Blackrock International Dividend Etf
$27.58
+1.58%
- Global Self Storage Inc
$5.16
+0.98%
Dbv Technologies S.a. - Spons-adr$9.96
+4.4%
- Santech Holdings Limited
$0.68
+15.25%
- Neos Etf Trust S&p 500 Hedged
$53.33
+0.49%
- Alps Clean Energy Etf
$29.10
+3.41%